Search results
InMed Pharmaceuticals (NASDAQ: INM) Announces Participation at Emerging Growth Conference
Digital Journal· 5 days agoInMed Pharmaceuticals is a clinical-stage pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates targeting the CB1/CB2 receptors ...